Until those results are in, the recommendation is extrapolated from non-pharmacologic weight-loss literature plus 2024-2025 case reports of GLP-1 patients who lifted and held their lean mass [11]
The Clinical Perspective: Experience Matters In our clinical experience at Revolution Health & Wellness , patients who use both forms strategically tend to achieve the best long-term results: Those with GI complaints (bloating, food reactivity, IBS, reflux) often respond best to oral BPC-157 first, then may transition to injectables later
They address different aspects of sexual function
Mounjaro, manufactured by Eli Lilly, contains tirzepatide
We wont know until we see you
Evaluation of the antibiotic properties of glutathione